1
|
Silva DL, de Barayazarra S, Valero A, Garcia E, Uriarte S, Peñaranda A, Chapman E, Garcia MB, Ocampo J, Valencia V, Moreno S, Corelli S, Lopez B, Ramírez LF, Pérez LC, Jares E, Serrano CD. Control of allergic rhinitis in four latin american countries: Rinola study. FRONTIERS IN ALLERGY 2022; 3:980515. [PMID: 36092279 PMCID: PMC9448887 DOI: 10.3389/falgy.2022.980515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2022] [Accepted: 08/01/2022] [Indexed: 11/13/2022] Open
Abstract
BackgroundAllergic rhinitis (AR) affects up to 40% of the general population, there are large-scale multicenter studies that have described its characteristics and few studies have focused on studying patients with AR in Latin America (LA).MethodologyA cross-sectional, descriptive, multicenter study was carried out in four LA countries (Colombia, Argentina, Cuba and Peru). Patients diagnosed with AR between November 2017 and June 2020 were included. Sociodemographic and clinical data, sensitization profile and current treatment were collected in the Electronic Data Collection (BDClinic). Patients also filled out this questionnaires: Rhinitis Control Assessment Test (RCAT), Reflexive Total Nasal Symptom Score (rTNSS), Modified ARIA Criteria for AR Severity (mARIA) and ESPRINT-15. Risk of bias was examined by applying the STROBE checklist.ResultsThe study included 412 patients. Median age was 25 years (15–39). Two hundred and twenty four (54.3%) were women. Nasal obstruction was present in 303 (73.5%). Three hundred and thirty four (81%) had a persistent AR. One hundred and twenty one (31.3%) had associated asthma. The most frequently positive skin tests were: Dermatophagoides pteronyssinus in 365 (88.6%) and Dermatophagoides farinae in 331 (81.3%). Four hundred and eleven patients (99%) reported that AR affected their quality of life. The median score of ESPRINT-15 was 1.87 (0.93–2.93), The mean values of RCAT and rTNSS were 19.01 (±4.59) and 5.4 (±2.97) respectively. Two hundred and fifty (60%) were receiving only oral antihistamines. Physicians decided to start nasal corticosteroids in 296 (71.8%). Only seventy patients (16.9%) were receiving immunotherapy.ConclusionThese findings confirm that most of patients with AR in LA have a persistent disease with a negative impact on quality of life. Dust mites are the main sensitizers. These findings will allow to know the true impact of AR and can lead to a better disease management.
Collapse
Affiliation(s)
- Diana L Silva
- Unidad de Alergologia, Fundación Valle del Lili, Cali, Colombia
| | | | - Antonio Valero
- Unidad De Alergia, Hospital Clínic, IDIBAPS, Barcelona, España
| | | | - Silvia Uriarte
- Departamento de Alergologia, Hospital Cayetano Heredia, Lima, Perú
| | | | | | - Maria B Garcia
- Departamento de Alergologia, Unimeq ORL, Bogotá, Colombia
| | - Jaime Ocampo
- Departamento de Alergologia, Unimeq ORL, Bogotá, Colombia
| | | | - Sergio Moreno
- Departamento de Alergologia, Unimeq ORL, Bogotá, Colombia
| | - Silvana Corelli
- Departamento de Alergologia, Hospital San Roque, Córdoba, Argentina
| | - Belkis Lopez
- Unidad De Alergia, Hospital Universitario General Calixto García, La Habana, Cuba
| | - Luis F Ramírez
- Unidad de Alergologia, Fundación Valle del Lili, Cali, Colombia
| | | | - Edgardo Jares
- Unidad De Alergia, Fundación LIBRA, Buenos Aires, Argentina
| | - Carlos D Serrano
- Unidad de Alergologia, Fundación Valle del Lili, Cali, Colombia
- Correspondence: Carlos Daniel Serrano Reyes
| |
Collapse
|
2
|
Moghtaderi M, Farjadian S, Hossieni Teshnizi S, Hadibarhaghtalab M. Allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization in patients with uncontrolled asthma: An experience from Southwestern Iran. Med J Islam Repub Iran 2019; 33:95. [PMID: 31696089 PMCID: PMC6825389 DOI: 10.34171/mjiri.33.95] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2017] [Indexed: 12/21/2022] Open
Affiliation(s)
- Mozhgan Moghtaderi
- Allergy Research Center, Allergy Clinic of Ali-Asghar Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Shirin Farjadian
- Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Saeed Hossieni Teshnizi
- Clinical Research Development Center of Children Hospital, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
| | | |
Collapse
|